Trial Profile
Open-label single-arm phase 2 study of ALIMTA plus cisplatin in Korean patients with advanced gastric carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2006
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 28 Jul 2006 Status change
- 28 Jul 2006 The expected completion date for this trial is now .
- 18 Nov 2005 New trial record.